In the previous study, positive coefficients indicated that the higher methylation expressions of RBPMS2 was associated with shorter survival of GC patients, suggesting methylation of RBPMS2 as a biomarker for GC [15]. This evidence concerns the gene RBPMS2 and gastric cancer.